Prevention and treatment of acute GvHD

@article{Messina2008PreventionAT,
  title={Prevention and treatment of acute GvHD},
  author={Carlo Messina and Maura Faraci and Vincenza De Fazio and Giorgio Dini and M. Cal{\`o} and Elisabetta Calore},
  journal={Bone Marrow Transplantation},
  year={2008},
  volume={41},
  pages={S65-S70}
}
  • Carlo Messina, Maura Faraci, +3 authors Elisabetta Calore
  • Published 2008
  • Medicine
  • Bone Marrow Transplantation
  • GvHD remains a source of significant morbidity and mortality in the setting of allogeneic haematopoietic SCT. Improving outcomes in stem cell transplant recipients requires additional therapeutic modalities for GvHD, especially for patients who fail to respond to initial therapy with steroids. Moreover, while the absence of acute GvHD (aGvHD) is associated with a higher risk of relapse of the underlying malignant disease, severe aGvHD usually induces the occurrence of life-threatening… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 34 CITATIONS, ESTIMATED 51% COVERAGE

    Mesenchymal stem cells targeting the GVHD

    FILTER CITATIONS BY YEAR

    2009
    2020

    CITATION STATISTICS

    • 1 Highly Influenced Citations

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 58 REFERENCES

    Management of acute graft-versus-host disease.

    VIEW 1 EXCERPT

    Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.

    Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.

    Pentostatin in steroid-refractory acute graft-versus-host disease.